Related references
Note: Only part of the references are listed.Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT
G. Edan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes A 10-Year Follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance
R. Philip Kinkel et al.
ARCHIVES OF NEUROLOGY (2012)
Evidence for a two-stage disability progression in multiple sclerosis
Emmanuelle Leray et al.
BRAIN (2010)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial
Ludwig Kappos et al.
LANCET NEUROLOGY (2009)
Will Rogers Phenomenon in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2008)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
Natural history of multiple sclerosis in a population-based cohort
M. Debouverie et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
M. Tintore et al.
NEUROLOGY (2008)
Baseline MRI predicts future attacks and disability in clinically isolated syndromes
M. Tintore et al.
NEUROLOGY (2006)
The natural history of multiple sclerosis: a geographically based study - 9: Observations on the progressive phase of the disease
M Kremenchutzky et al.
BRAIN (2006)
Disability progression in multiple sclerosis is slower than previously reported
H Tremlett et al.
NEUROLOGY (2006)
Is optic neuritis more benign than other first attacks in multiple sclerosis?
M Tintoré et al.
ANNALS OF NEUROLOGY (2005)
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
SJ Pittock et al.
NEUROLOGY (2004)
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
C Confavreux et al.
BRAIN (2003)
Interferons in relapsing remitting multiple sclerosis: a systematic review
G Filippini et al.
LANCET (2003)
Share Paper
